Trial in progress: A phase II, multicentre study to evaluate the efficacy and safety of birelentinib (DZD8586) combination therapy in diffuse large B-cell lymphoma (TAI-SHAN12)
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Huiqiang Huang, Wenyu Li, Liqun Zou, Yajun Li, Fang Zhu, Keshu Zhou, Yun Liang, Meifang Zheng, Zengjun Li, Hongmei Jing, Wei Yang, Pengcheng He, Kaiyang Ding, Yuhua Li, Mengling Zhong, Ziyi Liu, Liping Su
Institutions: Sun Yat-sen University Cancer Center, Guangdong Provincial People's Hospital, Sichuan University, West China Hospital of Sichuan University, Hunan Cancer Hospital, Zhujiang Hospital, Southern Medical University, Wuhan Union Hospital, Huazhong University of Science and Technology, Henan Cancer Hospital, Second Affiliated Hospital of Zhejiang University, Zhejiang University, Shandong Tumor Hospital, Peking University, Peking University Third Hospital, China Medical University, First Affiliated Hospital of Xi'an Jiaotong University, Dizal (Jiangsu) Pharmaceutical Co., Ltd. (China), Shanxi Provincial Cancer Hospital
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417015365
Cites:
Cited by:
Related to: